Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

NCT05316493 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

172

Enrollment

OTHER

Sponsor class

Conditions

Atypical Endometrial Hyperplasia
Fertility Issues
Overweight and Obesity

Interventions

BEHAVIORAL: Intensive Lifestyle Intervention (ILI)
DRUG: Megestrol Acetate 160 MG Oral Tablet
DRUG: Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg

Sponsor

Xiaojun Chen